Several papers out this week including in Cell & nature show that T cell recognition of #omicron #SARSCoV2 spike is maintained in most individuals after infection or vaccination cell.com/cell/fulltext/… nature.com/articles/s4158… nature.com/articles/s4158…

Last week, I had the incredible opportunity to speak at the #UnitedNations Science, Technology, and Innovation meeting on our work on a variant- proof #Tcell #COVID19 vaccine and the need to invest in young women and people of color in STEM. #WomenInSTEM 1/2

Humbled to receive this alongside Caroline Sokol MDPhD. Grateful to mentors, collaborators, lab members, family and friends who have provided so much support along the way.

Let’s go! Time for World Vaccine Congress in D.C. Join me and these superb panelists to discuss #HIVvaccines. #worldvaccinecongress

Grateful for this opportunity from NIDAnews to advance our HIV T cell vaccine work in new directions

So proud of Shaown Bhattacharyya, Charles Crain Charlie Crain and Ben Goldberg Ben Goldberg on their recent review of HIV-specific CD8+ T cells

Other evidence of the importance of T cells in control of viral induced disease(COVID in this case.).similar data in CART CD19 treated kids( see also doi:10.1182/blood .2022016166) | Science Translational Medicine science.org/doi/10.1126/sc…

Congrats to our collaborative group and especially to Reza Zonozi LucyClaire Aaron Shulkin and Vivek naranbhai on our new paper characterizing SARS-CoV-2 T cell responses and the value of the COVID-19 vaccines in B cell-deficient individuals.

Many thanks Ellie. Have been a long admirer of your work.

Although patients with #Bcell deficiencies lack antibodies, a new clinical study shows that #mRNA vaccines can still reduce the risk of severe #COVID19 in these individuals, including those treated with #rituximab, by enhancing T cell immunity. Science Translational Medicine scim.ag/5a5

The Ragon Institute, ReiThera Srl, and IAVI are pleased to announce a collaboration on the development of a novel HIV vaccine candidate that will be composed of GRAd vector and HIV T cell epitopes, funded by the Bill & Melinda Gates Foundation. ragoninstitute.org/latest-news/re…

So proud of Rhoda Kesewaa Tano-Menka and team on our recent work published in Structure elucidating genetic contributions to HIV control cell.com/structure/full…

Polymorphic residues in HLA-B that mediate #HIV control distinctly modulate peptide interactions with both TCR and KIR molecules Structure Senior author is A/Prof Gaiha Gaurav – Gaurav Gaiha buff.ly/3UxO3Ty

So proud of Dr ⁦⁦Anusha Nathan, PhD⁩ on her PhD from the Harvard Immunology program. Amazing scientist and person. Such a privilege to be her mentor over the past 4 years

Deep learning enhances the prediction of HLA class I-presented CD8+ T cell epitopes in foreign pathogens nature.com/articles/s4225… Regina Barzilay Gaurav Gaiha Jeremy Wohlwend Anusha Nathan, PhD Nature Machine Intelligence

Thrilled to share the result of our collaboration with @reginabarzilay: MUNIS - an AI-based tool for T cell epitope prediction. We look forward to applying towards vaccine development for infectious pathogens. Congrats to Jeremy Wohlwend Anusha Nathan, PhD nature.com/articles/s4225…

Researchers at the Ragon & MIT have developed MUNIS, an AI tool that enhances T cell epitope prediction—a key step in vaccine design. This breakthrough could advance infectious disease research, cancer immunotherapy & more. Learn more: ow.ly/NTU250UOTRA #AI #Immunology

How can deep learning improve the prediction of CD8+ T cell epitopes to accelerate vaccine development?MIT Jameel Clinic for AI & Health Nature Machine Intelligence "Deep learning enhances the prediction of HLA class I-presented CD8+ T cell epitopes in foreign pathogens" • A major challenge in T cell vaccine

So proud of Anusha Nathan, PhD on this amazing achievement! So well deserved!!

Excited for this moment, many years in the making.